Treatment of Hormone-Refractory Breast Cancer: Apoptosis and Regression of Human Tumors Implanted in Mice

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Addition of Everolimus and Trastuzumab to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2019English

Patterns of Regression in Breast Cancer After Primary Systemic Treatment

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2018English

Hormone-Refractory Prostate Cancer

English

Rhein Induces Apoptosis in Human Breast Cancer Cells

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2012English

Achieving Treatment Goals for Hormone-Refractory Prostate Cancer With Chemotherapy

Oncologist
Cancer ResearchMedicineOncology
2005English

Somatic Loss of BRCA1 and P53 in Mice Induces Mammary Tumors With Features of Human BRCA1-mutated Basal-Like Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Regression of Prostate Tumors Upon Combination of Hormone Ablation Therapy and Celecoxib in Vivo

Prostate
OncologyUrology
2010English

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2019English

Stromal Immunoglobulin κC Expression Is Associated With Initiation of Breast Cancer in TA2 Mice and Human Breast Cancer

Cancer Science
Cancer ResearchMedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy